IRWD · Ironwood Pharmaceuticals Inc

$4.31 +0.23 (+5.64%) At close · Aug 14

Market Cap

$712.18M

165.24M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized

$150,000,000

as of 2021-05-31 · not restated in filings since 2025-03-31

Remaining Authorization

$32,400,000

as of 2022-03-31 · not restated in filings since 2022-05-05

Program Utilization

78.4% $117,600,000 used of $150,000,000

Cash spent on buybacks by quarter

Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended	Cash Spent	Shares	Avg Price	Source
2022-12-31	$126,394,000	10,800,000	—	10-K, filed 2025-03-31
2021-12-31	$24,131,000	2,400,000	—	10-K, filed 2024-02-16

Quarter Ended	Cash Spent	Shares	Avg Price	Source
2022-12-31	$0 Δ	—	—	10-K, filed 2025-03-31
2022-09-30	$0 Δ	—	—	10-Q, filed 2023-11-09
2022-06-30	$33,899,000 Δ	2,800,000	—	10-Q, filed 2023-08-09
2022-03-31	$92,495,000	8,000,000	—	10-Q, filed 2023-05-04

Key facts CIK 1446847 CUSIP 46333X108 13F (30d) 208 filings 201 filers Visit website Investor relations